Diamond House Detox

Diamond House Detox

Services:
Type of Care
• Substance use treatment
• Detoxification
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Gender Accepted

• Male
• Female

Detoxification (medical withdrawal) Services

• Alcohol Detoxification
• Opioids detoxification
• Cocaine Detoxification
• Medication routinely used during detoxification
• Benzodiazepines Detoxification
• Methamphetamines detoxification

Facility Smoking Policy

• Smoking permitted in designated area

Pharmacotherapies

• Medication for mental disorders
• Naltrexone (extended-release, injectable)
• Naltrexone (oral)
• Nicotine replacement
• Buprenorphine without naloxone
• Buprenorphine with naloxone
• Disulfiram
• Non-nicotine smoking/tobacco cessation
• Acamprosate (Campral®)
• Clonidine

Education and Counseling Services

• Substance use disorder education
• Individual counseling
• Family counseling
• Group counseling
• Smoking/vaping/tobacco cessation counseling

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Private health insurance

Age Groups Accepted

• Young Adults
• Adults

Recovery Support Services

• Assistance with obtaining social services
• Housing services
• Self-help groups
• Mentoring/peer support

Special Programs/Groups Offered

• Clients with co-occurring mental and substance use disorders

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

External Opioid Medications Source

• Other contracted prescribing entity
• No formal relationship with prescribing entity
• In-network prescribing entity

Testing

• Drug or alcohol urine screening
• Breathalyzer or blood alcohol testing
• TB screening

Ancillary Services

• Mental health services
• Case management service

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• In-network prescribing entity
• Other contracted prescribing entity

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Treatment Approaches

• Cognitive behavioral therapy
• 12-step facilitation
• Substance use disorder counseling
• Trauma-related counseling
• Motivational interviewing
• Relapse prevention
• Matrix Model
• Brief intervention
• Contingency management/motivational incentives
• Anger management
• Telemedicine/telehealth therapy

Transitional Services

• Outcome follow-up after discharge
• Aftercare/continuing care
• Discharge Planning
• Naloxone and overdose education

Type of Opioid Treatment

• Buprenorphine detoxification
• Buprenorphine maintenance
• Prescribes naltrexone
• Lofexidine or Clonidine detoxification
• Accepts clients using MAT but prescribed elsewhere
• Relapse prevention with naltrexone
• Maintenance service with medically supervised withdrawal after stabilization
• Prescribes buprenorphine

Facility Vaping Policy

• Vaping permitted in designated area

Assessment/Pre-treatment

• Comprehensive mental health assessment
• Screening for substance use
• Comprehensive substance use assessment
• Screening for mental disorders
• Screening for tobacco use

License/Certification/Accreditation

• The Joint Commission
• State department of health

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Residential/24-hour residential
• Residential detoxification
• Short-term residential